Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance - Wikidata - awgldk - TriplyDB

Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance

Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance

http://www.wikidata.org/entity/Q36282200

about

Molecular and Cellular Mechanisms of Action of Tumour Suppressor GAS5 LncRNA Targeting caspases in cancer therapeutics Methylarsonous acid causes oxidative DNA damage in cells independent of the ability to biomethylate inorganic arsenic Caveolae contribute to the apoptosis resistance induced by the alpha(1A)-adrenoceptor in androgen-independent prostate cancer cells Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastases.CellFrame: a data structure for abstraction of cell biology experiments and construction of perturbation networks.DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance.Therapeutic value of quinazoline-based compounds in prostate cancer.Androgen receptor as a driver of therapeutic resistance in advanced prostate cancer.Arsenic-specific stem cell selection during malignant transformation.MUC1 contributes to BPDE-induced human bronchial epithelial cell transformation through facilitating EGFR activation.Protein kinase CK2 in health and disease: CK2: a key player in cancer biology Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult.Nonautophagic cytoplasmic vacuolation death induction in human PC-3M prostate cancer by curcumin through reactive oxygen species -mediated endoplasmic reticulum stress Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer.The hormone response element mimic sequence of GAS5 lncRNA is sufficient to induce apoptosis in breast cancer cells.PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT.Sensitivity of human prostate cancer cells to chemotherapeutic drugs depends on EndoG expression regulated by promoter methylation Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.Polyisoprenylated methylated protein methyl esterase overexpression and hyperactivity promotes lung cancer progression.Targeting anoikis resistance in prostate cancer metastasis.Tumor promotion via injury- and death-induced inflammation New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy.Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.MicroRNAs as putative mediators of treatment response in prostate cancer.Inhibition of apoptosis in prostate cancer cells by androgens is mediated through downregulation of c-Jun N-terminal kinase activation.Personalized prostate cancer therapy based on systems analysis of the apoptosis regulatory network.Mechanisms of Therapeutic Resistance in Prostate Cancer.Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer.Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy.Anoikis and EMT: Lethal "Liaisons" during Cancer Progression.Induction of reactive oxygen species generation inhibits epithelial-mesenchymal transition and promotes growth arrest in prostate cancer cells Constitutively active Akt contributes to vincristine resistance in human retinoblastoma cells.Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75.Ceramide metabolism determines glioma cell resistance to chemotherapy.Targeted induction of apoptosis via TRAIL and cryoablation: a novel strategy for the treatment of prostate cancer.Why stress is BAD for cancer patients

P2860

Q26801277-B83D6F15-7415-4E61-8983-F80B227182D2 Q26821986-5238477C-243F-4A4A-888D-4B8AC90DD37F Q28397241-1F74EF2B-D6D6-477D-B724-7347BDCE7094 Q28476183-2090A9FB-0307-4C94-A416-941F07D192C5 Q30572057-094CAEAD-01C8-403E-B0E9-EA2C7E49BA54 Q31132649-3AF5F3B7-A6AF-479F-8356-200C5C6415F9 Q33586771-C913128C-466D-436F-9D69-33F3BAB829D6 Q33718142-AD18A25C-822E-4CBC-86E3-F32A5F03212D Q33746225-3FBD9930-7B29-42E7-AAE3-B7480FC0DF58 Q33775723-17D7700E-C5C4-4CED-AE12-4D5E701C1AF7 Q33828693-F371995C-A2BD-4681-9AED-7D2EBAA0C310 Q34212005-8D1B697B-DA8B-4A8A-BA8A-C44FF6F9D443 Q35270830-4780ED65-E531-4CC8-BCE5-B2887444E885 Q35645461-EF2B974A-96FC-4A6F-9F49-5D67B24A5A69 Q35651345-8F7E7C15-BAEE-4B7F-8108-3583F12242C0 Q35806990-9D6D1736-DD1C-4A3E-B50D-0EF1C5C7AFCB Q36962890-B49E632C-52C9-4BEF-A4E2-34C5AD475532 Q37038041-BCB07B99-F7B1-4E6C-9C2A-BCA3287E411F Q37302354-BC5F2731-768E-4B92-8A71-234875DA0DC6 Q37388422-0E89D7B4-9B09-4F15-9AB9-C0F627B5D5B6 Q37401741-E7B0EFBA-3787-4F10-8A96-A0153A612224 Q37487082-A17BC463-B640-4DC5-811C-96AD4E43E00E Q37650129-58E10CE4-C5C4-4359-BA3F-27AEA7861F8D Q37691830-9A18D2C5-C5A5-48AE-A1C9-560FB6D6E1ED Q37950602-23F6269F-45CA-43DD-B29C-2CCE12459947 Q37981834-64B42597-4A38-4EA9-AF09-789766A4EBA3 Q37988364-133052D0-CABC-4573-9DEB-283610940C5C Q38011943-E868D677-D3FF-436A-B18F-2CB90919C8FD Q38271452-42E330DB-8830-42B0-88FF-685330926480 Q38314425-AA01CD19-C9D7-4ABF-B67C-AE0713BBD5C8 Q38754316-945A1ABF-C94B-4106-A92F-1A9DEEE96116 Q38897955-7504E1DC-035D-40FC-AEF1-57148364B39C Q38999344-8F3B3B91-B5B1-4CB3-BBC5-327AF92F3F16 Q39028687-65D433DA-BB27-4AB4-82EA-7A66A46E12B1 Q39182893-C5076389-2455-4263-9EAC-8576A6E07946 Q39766082-4BA8B802-A7A9-40C7-A021-FAD9F268DE80 Q39806758-23CFE0CC-841F-4E1A-B935-3730DBD91D8F Q39807508-9F21759A-411C-4362-8042-9AE9B5F0FE36 Q40171532-F81E28E0-A916-4B1C-9175-3FBC65CBDC18 Q42127137-772C1454-609D-4A2D-B914-32B94B0635C0

P2860

Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance

http://www.wikidata.org/entity/Q36282200

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Apoptosis evasion: the role of ...... ion and therapeutic resistance

@ast

Apoptosis evasion: the role of ...... ion and therapeutic resistance

@en

type

label

Apoptosis evasion: the role of ...... ion and therapeutic resistance

@ast

Apoptosis evasion: the role of ...... ion and therapeutic resistance

@en

prefLabel

Apoptosis evasion: the role of ...... ion and therapeutic resistance

@ast

Apoptosis evasion: the role of ...... ion and therapeutic resistance

@en

P1433

Q36282200-4BF7AA14-8E60-4926-B33A-D9BF25611DB9

P1476

Q36282200-B37CC4ED-9275-49EA-A936-F3EDCCCC6393

P2093

Q36282200-064CA045-4D85-427D-A6CD-88550A5C45DF

Q36282200-0BCE28A4-BC93-43EE-858D-957347FA6C59

P2860

Q36282200-004738A9-AAE5-409F-B4B1-130748CAAFC5

Q36282200-01EC0A73-1D99-4D30-85E2-F4A2B792005E

Q36282200-050D0FEC-DC7A-46D2-BAD1-BFE6EC945C3E

Q36282200-08DA3F12-B2DA-4A11-ADFD-066FD851FE3F

Q36282200-0A0C1F9B-BA92-408B-B552-018C85073F10

Q36282200-0CE98BC8-D82D-41D7-B876-60E515EBC1C4

Q36282200-0CEC5099-6EB1-4491-87F2-4F87B4165A67

Q36282200-0E9877D4-3641-4B86-8F1B-BE2C09A0A327

Q36282200-0E9D38D3-EB9A-4FD7-8187-0A5638133B64

Q36282200-0FFC9473-593C-40F4-B431-A9F9BDD25D56

P304

Q36282200-EF2654BB-E4B0-4095-8A4F-B2320CFE52AA

P31

Q36282200-CF72FE59-FC3D-43F6-8390-D6DD3ABE3986

P356

Q36282200-C77CEE71-B618-4C71-A963-478AF5FF4289

P433

Q36282200-73772ECB-CC12-405C-9220-11E3525B31A7

P478

Q36282200-39DFB261-27E1-4D53-B742-1DED6733763B

P577

Q36282200-AC09CC91-DFAD-4824-9EC5-78021AA1A658

P5875

Q36282200-44DE0912-8125-4232-8DFC-3881AF5DE9AC

P698

Q36282200-08AB6EFD-5835-4A16-AE57-0ABE5F5FFC70

P921

Q36282200-2502DCF5-131F-4458-9468-233090717BF1

P932

Q36282200-C5EC6670-0B42-43B8-B97A-ABAA9FDEC0B9

P356

P1433

Journal of Cellular Biochemistry

P1476

Apoptosis evasion: the role of ...... ion and therapeutic resistance

@en

P2093

Natasha Kyprianou

http://www.w3.org/2001/XMLSchema#string

Shaun McKenzie

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Endogenous inhibitors of nuclear factor-kB, an opportunity for cancer control

Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?

Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression

Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model

Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

P304

18-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.20634

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7549911

http://www.w3.org/2001/XMLSchema#string

P698

16216007

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

2274918

http://www.w3.org/2001/XMLSchema#string